SILK - Silk Road Medical, Inc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.28B
Enterprise Value 31.33B
Trailing P/E N/A
Forward P/E 1-689.17
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)22.71
Price/Book (mrq)16.43
Enterprise Value/Revenue 323.73
Enterprise Value/EBITDA 6-49.15

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 311.92%
52 Week High 351.50
52 Week Low 327.83
50-Day Moving Average 344.86
200-Day Moving Average 338.44

Share Statistics

Avg Vol (3 month) 3317.94k
Avg Vol (10 day) 3263.73k
Shares Outstanding 530.87M
Float 23.96M
% Held by Insiders 13.20%
% Held by Institutions 1109.92%
Shares Short (Jan 30, 2020) 41.14M
Short Ratio (Jan 30, 2020) 43.57
Short % of Float (Jan 30, 2020) 412.42%
Short % of Shares Outstanding (Jan 30, 2020) 43.70%
Shares Short (prior month Dec 30, 2019) 41.3M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -106.32%
Operating Margin (ttm)-49.57%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)56.19M
Revenue Per Share (ttm)3.29
Quarterly Revenue Growth (yoy)77.10%
Gross Profit (ttm)23.68M
EBITDA -27.13M
Net Income Avi to Common (ttm)-59.74M
Diluted EPS (ttm)-3.49
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)112.28M
Total Cash Per Share (mrq)3.64
Total Debt (mrq)49.43M
Total Debt/Equity (mrq)63.83
Current Ratio (mrq)10.61
Book Value Per Share (mrq)2.52

Cash Flow Statement

Operating Cash Flow (ttm)-29.74M
Levered Free Cash Flow (ttm)N/A